Related changes

Jump to: navigation, search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 01:18, 11 May 2021
   
Page name:

10 May 2021

 m   22:04  Breast cancer‎‎ (4 changes | history) . . (+677). . [Warner-admin‎; Jwarner‎ (3×)]
 m    22:04 (cur | prev) . . (+657). . Jwarner (talk | contribs) (References)
 m    22:01 (cur | prev) . . (-1). . Jwarner (talk | contribs) (Subsequent treatment)
 m    21:50 (cur | prev) . . (+12). . Jwarner (talk | contribs) (Epirubicin & Paclitaxel (EP) {{#subobject:38119e|Regimen=1}})
 m    20:45 (cur | prev) . . (+9). . Warner-admin (talk | contribs) (Text replacement - "====Hormonotherapy====" to "====Endocrine therapy====")
 m   22:03  Complex multipart regimens‎ (diff | hist) . . (+657). . Jwarner (talk | contribs) (Kümmel et al. 2006)
 m   21:42  Breast cancer, HER2-positive‎‎ (3 changes | history) . . (+1,065). . [Jwarner‎ (3×)]
 m    21:42 (cur | prev) . . (+1,019). . Jwarner (talk | contribs) (THP (Taxotere) {{#subobject:938b69|Regimen=1}})
 m    11:15 (cur | prev) . . (-265). . Jwarner (talk | contribs) (Cyclophosphamide & Doxorubicin (AC) {{#subobject:647f67|Regimen=1}})
 m    08:17 (cur | prev) . . (+311). . Jwarner (talk | contribs)
 m   20:47  Breast cancer - historical‎ (diff | hist) . . (+90). . Warner-admin (talk | contribs) (Text replacement - "====Hormonotherapy====" to "====Endocrine therapy====")
 m   16:51  Diffuse large B-cell lymphoma‎‎ (3 changes | history) . . (+424). . [Jwarner‎ (3×)]
 m    16:51 (cur | prev) . . (+452). . Jwarner (talk | contribs) (References)
 m    16:50 (cur | prev) . . (-33). . Jwarner (talk | contribs) (Bendamustine & Rituximab (BR) & Polatuzumab vedotin {{#subobject:1cc486|Regimen=1}})
 m    13:55 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Lenalidomide & Tafasitamab {{#subobject:d4abx3|Regimen=1}})
 m   11:55  Colon cancer‎ (diff | hist) . . (0). . Jwarner (talk | contribs) (Nivolumab monotherapy {{#subobject:ac98g4|Regimen=1}})
     09:52  Tutorial‎‎ (2 changes | history) . . (-91). . [PeterYang‎; Jwarner‎]
 m    09:52 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Preferred name)
      02:29 (cur | prev) . . (-96). . PeterYang (talk | contribs) (Ontology) (Tag: Visual edit)

9 May 2021

 m   21:49  Diffuse large B-cell lymphoma - historical‎ (diff | hist) . . (-120). . Jwarner (talk | contribs)
 m   21:21  Breast cancer‎‎ (2 changes | history) . . (+729). . [Jwarner‎ (2×)]
 m    21:21 (cur | prev) . . (+564). . Jwarner (talk | contribs) (References)
 m    20:15 (cur | prev) . . (+165). . Jwarner (talk | contribs) (ASCO)
 m   20:14  Breast cancer, HER2-positive‎‎ (2 changes | history) . . (+8,975). . [Jwarner‎ (2×)]
 m    20:14 (cur | prev) . . (+165). . Jwarner (talk | contribs) (ASCO)
 m    20:11 (cur | prev) . . (+8,810). . Jwarner (talk | contribs)
 m   17:14  Colon cancer‎ (diff | hist) . . (+1,183). . Jwarner (talk | contribs) (mFOLFOX6 {{#subobject:32d6c5|Regimen=1}})

8 May 2021

     21:32  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+1,631). . Jwarner (talk | contribs) (Temsirolimus monotherapy {{#subobject:4baa29|Regimen=1}})

7 May 2021

 m   22:09  Drug index‎ (diff | hist) . . (+35). . Jwarner (talk | contribs) (G)
 m   22:03  Complex multipart regimens‎ (diff | hist) . . (-1,279). . Jwarner (talk | contribs) (HERBY)

6 May 2021

 m   13:49  Breast cancer, HER2-positive‎‎ (2 changes | history) . . (+20). . [Jwarner‎ (2×)]
 m    13:49 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Capecitabine & Neratinib {{#subobject:01baec|Regimen=1}})
 m    13:46 (cur | prev) . . (+15). . Jwarner (talk | contribs)

5 May 2021

 m   21:02  Breast cancer, HER2-positive‎ (diff | hist) . . (+57). . Jwarner (talk | contribs)

4 May 2021

 m   09:12  Renal cell carcinoma‎ (diff | hist) . . (+12). . Jwarner (talk | contribs)
 m   09:08  Melanoma‎ (diff | hist) . . (+2). . Jwarner (talk | contribs) (Ipilimumab monotherapy {{#subobject:fab3f4|Regimen=1}})